Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

A designed cell-penetrating human SOCS2 protein suppresses GH-dependent cancer cell proliferation.

Miyamoto A, Masuhiro Y, Seki T, Hanazawa S, Shiba H.

Biosci Biotechnol Biochem. 2019 Feb;83(2):300-308. doi: 10.1080/09168451.2018.1536516. Epub 2018 Oct 22.

PMID:
30343638
2.

The telomere binding protein Pot1 maintains haematopoietic stem cell activity with age.

Hosokawa K, MacArthur BD, Ikushima YM, Toyama H, Masuhiro Y, Hanazawa S, Suda T, Arai F.

Nat Commun. 2017 Oct 6;8(1):804. doi: 10.1038/s41467-017-00935-4.

3.

Functional analysis of Protection of Telomeres 1a (Pot1a) in regulation of hematopoietic stem cell aging.

Hosokawa K, Macarthur BD, Ikushima Y, Toyama H, Masuhiro Y, Hanazawa S, Suda T, Arai F.

Rinsho Ketsueki. 2017;58(8):942-949. doi: 10.11406/rinketsu.58.942. Japanese.

PMID:
28883279
4.

TIPE2 (Tumor Necrosis Factor α-induced Protein 8-like 2) Is a Novel Negative Regulator of TAK1 Signal.

Oho M, Nakano R, Nakayama R, Sakurai W, Miyamoto A, Masuhiro Y, Hanazawa S.

J Biol Chem. 2016 Oct 21;291(43):22650-22660. Epub 2016 Sep 6.

5.

Manipulation of Cell Cycle and Chromatin Configuration by Means of Cell-Penetrating Geminin.

Ohno Y, Suzuki-Takedachi K, Yasunaga S, Kurogi T, Santo M, Masuhiro Y, Hanazawa S, Ohtsubo M, Naka K, Takihara Y.

PLoS One. 2016 May 19;11(5):e0155558. doi: 10.1371/journal.pone.0155558. eCollection 2016.

6.

Modulation of the EMT/MET process by pyrrole-imidazole polyamide targeting human transforming growth factor-β1.

Saito K, Fukuda N, Shinohara K, Masuhiro Y, Hanazawa S, Matsuda H, Fujiwara K, Ueno T, Soma M.

Int J Biochem Cell Biol. 2015 Sep;66:112-20. doi: 10.1016/j.biocel.2015.07.011. Epub 2015 Jul 26.

PMID:
26222185
7.

Antiviral protection mechanisms mediated by ginbuna crucian carp interferon gamma isoforms 1 and 2 through two distinct interferon gamma-receptors.

Yabu T, Toda H, Shibasaki Y, Araki K, Yamashita M, Anzai H, Mano N, Masuhiro Y, Hanazawa S, Shiba H, Moritomo T, Nakanishi T.

J Biochem. 2011 Dec;150(6):635-48. doi: 10.1093/jb/mvr108. Epub 2011 Sep 7.

PMID:
21903635
8.

Identification of significant regions of transcription factor DP-1 (TFDP-1) involved in stability/instability of the protein.

Arakawa T, Masuhiro Y, Kamiya Y, Kojima H, Hanazawa S.

Biochem Biophys Res Commun. 2010 Jun 25;397(2):345-9. doi: 10.1016/j.bbrc.2010.05.127. Epub 2010 May 27.

PMID:
20513349
9.

SOCS-3 inhibits E2F/DP-1 transcriptional activity and cell cycle progression via interaction with DP-1.

Masuhiro Y, Kayama K, Fukushima A, Baba K, Soutsu M, Kamiya Y, Gotoh M, Yamaguchi N, Hanazawa S.

J Biol Chem. 2008 Nov 14;283(46):31575-83. doi: 10.1074/jbc.M800328200. Epub 2008 Aug 7.

10.

Induction of Porphyromonas gingivalis GroEL signaling via binding to Toll-like receptors 2 and 4.

Argueta JG, Shiota S, Yamaguchi N, Masuhiro Y, Hanazawa S.

Oral Microbiol Immunol. 2006 Aug;21(4):245-51.

PMID:
16842509
11.

Adiponectin inhibits Toll-like receptor family-induced signaling.

Yamaguchi N, Argueta JG, Masuhiro Y, Kagishita M, Nonaka K, Saito T, Hanazawa S, Yamashita Y.

FEBS Lett. 2005 Dec 19;579(30):6821-6. Epub 2005 Nov 28.

12.

Function of nuclear sex hormone receptors in gene regulation.

Kato S, Sato T, Watanabe T, Takemasa S, Masuhiro Y, Ohtake F, Matsumoto T.

Cancer Chemother Pharmacol. 2005 Nov;56 Suppl 1:4-9. Review.

PMID:
16273365
13.

Splicing potentiation by growth factor signals via estrogen receptor phosphorylation.

Masuhiro Y, Mezaki Y, Sakari M, Takeyama K, Yoshida T, Inoue K, Yanagisawa J, Hanazawa S, O'malley BW, Kato S.

Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8126-31. Epub 2005 May 26.

14.

Identification and characterization of novel isoforms of human DP-1: DP-1{alpha} regulates the transcriptional activity of E2F1 as well as cell cycle progression in a dominant-negative manner.

Ishida H, Masuhiro Y, Fukushima A, Argueta JG, Yamaguchi N, Shiota S, Hanazawa S.

J Biol Chem. 2005 Jul 1;280(26):24642-8. Epub 2005 Apr 29.

16.

A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA.

Watanabe M, Yanagisawa J, Kitagawa H, Takeyama K, Ogawa S, Arao Y, Suzawa M, Kobayashi Y, Yano T, Yoshikawa H, Masuhiro Y, Kato S.

EMBO J. 2001 Mar 15;20(6):1341-52. Retraction in: EMBO J. 2014 Dec 1;33(23):2880.

17.

Molecular mechanism of a cross-talk between oestrogen and growth factor signalling pathways.

Kato S, Masuhiro Y, Watanabe M, Kobayashi Y, Takeyama KI, Endoh H, Yanagisawa J.

Genes Cells. 2000 Aug;5(8):593-601. Review.

18.

Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators.

Kodera Y, Takeyama K, Murayama A, Suzawa M, Masuhiro Y, Kato S.

J Biol Chem. 2000 Oct 27;275(43):33201-4. Retraction in: J Biol Chem. 2013 Oct 18;288(42):30505.

19.

p300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor alpha and beta by interacting directly with the N-terminal A/B domains.

Kobayashi Y, Kitamoto T, Masuhiro Y, Watanabe M, Kase T, Metzger D, Yanagisawa J, Kato S.

J Biol Chem. 2000 May 26;275(21):15645-51.

20.

p300/CBP acts as a coactivator of the cone-rod homeobox transcription factor.

Yanagi Y, Masuhiro Y, Mori M, Yanagisawa J, Kato S.

Biochem Biophys Res Commun. 2000 Mar 16;269(2):410-4.

PMID:
10708567
21.

Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha.

Endoh H, Maruyama K, Masuhiro Y, Kobayashi Y, Goto M, Tai H, Yanagisawa J, Metzger D, Hashimoto S, Kato S.

Mol Cell Biol. 1999 Aug;19(8):5363-72. Retraction in: Mol Cell Biol. 2014 Mar;34(5):915.

22.

Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators.

Yanagisawa J, Yanagi Y, Masuhiro Y, Suzawa M, Watanabe M, Kashiwagi K, Toriyabe T, Kawabata M, Miyazono K, Kato S.

Science. 1999 Feb 26;283(5406):1317-21.

23.

Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog.

Takeyama K, Masuhiro Y, Fuse H, Endoh H, Murayama A, Kitanaka S, Suzawa M, Yanagisawa J, Kato S.

Mol Cell Biol. 1999 Feb;19(2):1049-55.

24.

Molecular mechanism of a cross-talk between estrogen and growth-factor signaling pathways.

Kato S, Kitamoto T, Masuhiro Y, Yanagisawa J.

Oncology. 1998 Dec;55 Suppl 1:5-10. Review.

PMID:
9852396
25.

A putative tumor suppressor, TSG101, acts as a transcriptional suppressor through its coiled-coil domain.

Watanabe M, Yanagi Y, Masuhiro Y, Yano T, Yoshikawa H, Yanagisawa J, Kato S.

Biochem Biophys Res Commun. 1998 Apr 28;245(3):900-5.

PMID:
9588212
26.

ERC-55, a binding protein for the papilloma virus E6 oncoprotein, specifically interacts with vitamin D receptor among nuclear receptors.

Imai T, Matsuda K, Shimojima T, Hashimoto T, Masuhiro Y, Kitamoto T, Sugita A, Suzuki K, Matsumoto H, Masushige S, Nogi Y, Muramatsu M, Handa H, Kato S.

Biochem Biophys Res Commun. 1997 Apr 28;233(3):765-9.

PMID:
9168930
27.

Intron retention generates a novel isoform of the murine vitamin D receptor that acts in a dominant negative way on the vitamin D signaling pathway.

Ebihara K, Masuhiro Y, Kitamoto T, Suzawa M, Uematsu Y, Yoshizawa T, Ono T, Harada H, Matsuda K, Hasegawa T, Masushige S, Kato S.

Mol Cell Biol. 1996 Jul;16(7):3393-400.

28.

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase.

Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P.

Science. 1995 Dec 1;270(5241):1491-4.

PMID:
7491495
29.

Transcriptional activity of a fluorinated vitamin D analog on VDR-RXR-mediated gene expression.

Sasaki H, Harada H, Handa Y, Morino H, Suzawa M, Shimpo E, Katsumata T, Masuhiro Y, Matsuda K, Ebihara K, et al.

Biochemistry. 1995 Jan 10;34(1):370-7.

PMID:
7819220

Supplemental Content

Loading ...
Support Center